Atlas Trials

Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast Cancer

Clinical trial NCT05933733 · RECRUITING

Trial details

NCT number
NCT05933733
Sponsor
Samsung Medical Center
Status
RECRUITING
Study type
OBSERVATIONAL
Breast Cancer
Start date
2023-07-04
Primary completion
2028-07-01
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.